Soft Tissue Manipulation Alters RANTES/CCL5 and IL-4 Cytokine Levels in a Rat Model of Chronic Low Back Pain DOI Open Access

Carmela L. Marciano,

Taylor Hiland,

Krista L. Jackson

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(18), P. 14392 - 14392

Published: Sept. 21, 2023

Low back pain (LBP) is a common musculoskeletal complaint that can impede physical function and mobility. Current management often involves medication, but there need for non-pharmacological non-invasive interventions. Soft tissue manipulation (STM), such as massage, has been shown to be effective in human subjects, the molecular mechanisms underlying these findings are not well understood. In this paper, we evaluated potential changes soft levels of more than thirty pro- or anti-inflammatory cytokines following instrument-assisted STM (IASTM) rats with chronic, induced LBP using Complete Freund's Adjuvant. Our results indicate IASTM associated reduced Regulated on Activation, Normal T cell Expressed Secreted (RANTES)/Chemokine (C-C motif) ligand 5 (CCL5) increased Interleukin (IL)-4, which pro-inflammatory factors, respectively, by 120 min post-treatment. was tissue-level C-X-C Motif Chemokine Ligand (CXCL)-5/Lipopolysaccharide-Induced CXC (LIX)-which murine homologue IL-8, CXCL-7, Granulocyte-Macrophage-Colony Simulating Factor (GM-CSF), Intercellular Adhesion Molecule (ICAM)-1, IL1-Receptor Antagonist (IL-1ra), IL-6, Interferon-Inducible Protein (IP)-10/CXCL-10, L-selectin, Tumor Necrosis (TNF)-α, Vascular Endothelial Growth (VEGF) at either 30 Combined, our raise possibility may exert effects improved clinical outcomes potentially beneficial pro-/anti-inflammatory circulation level.

Language: Английский

Unveiling the role of CXCL8/CXCR2 in intervertebral disc degeneration: A path to promising therapeutic strategies DOI Creative Commons
Pengfei Xue,

Long Lv,

Lei Liu

et al.

Journal of Orthopaedic Translation, Journal Year: 2024, Volume and Issue: 49, P. 119 - 134

Published: Oct. 9, 2024

Language: Английский

Citations

3

Immunomorphogenesis in Degenerative Disc Disease: The Role of Proinflammatory Cytokines and Angiogenesis Factors DOI Creative Commons

Natalya G. Pravdyuk,

А. В. Новикова, Н. А. Шостак

et al.

Biomedicines, Journal Year: 2023, Volume and Issue: 11(8), P. 2184 - 2184

Published: Aug. 3, 2023

Back pain (BP) due to degenerative disc disease (DDD) is a severe, often disabling condition. The aim of this study was determine the association between expression level proinflammatory cytokines (IL-1β, IL-6, and IL-17), angiogenesis markers (VEGF-A CD31) in intervertebral (IVD) tissue IVD degeneration young people with discogenic BP. In patients who underwent discectomy for herniation, clinical examination, magnetic resonance imaging lumbar spine, histological immunohistochemical analyses these factors were performed comparison parameters healthy group samples (controls). Histology image analysis fragments DDD detected zones inflammatory infiltration, combined vascularization, presence granulation clusters chondrocytes nucleus pulposus (NP). Statistically significant increased IL-1β, IL-17, VEGF-A CD31 evident compared controls, that showed strong correlation stage. Our results denote an immunoinflammatory potential demonstrates their altered morphogenetic properties, also NP cells may trigger angiogenesis.

Language: Английский

Citations

7

High-Tech Methods of Cytokine Imbalance Correction in Intervertebral Disc Degeneration DOI Open Access
N. А. Shnayder,

Azamat V. Ashhotov,

Vera V. Trefilova

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(17), P. 13333 - 13333

Published: Aug. 28, 2023

An important mechanism for the development of intervertebral disc degeneration (IDD) is an imbalance between anti-inflammatory and pro-inflammatory cytokines. Therapeutic non-therapeutic approaches cytokine correction in IDD either do not give expected result, or a short period time. This explains relevance high-tech medical care, which part specialized care includes use new resource-intensive methods treatment with proven effectiveness. The aim review to update knowledge about based on IDD. It demonstrates promise management patients resistant previously used therapies, including: cell therapy (stem implantation, implantation autologous cultured cells, tissue engineering); genetic technologies (gene modifications, microRNA, molecular inducers IDD); influencing inflammatory cascade discs mediated by abnormal activation inflammasomes; senolytics; exosomal therapy; other factors (hypoxia-induced factors; lysyl oxidase; corticostatin; etc.).

Language: Английский

Citations

7

Visualizing the bibliometrics of the inflammatory mechanisms in intervertebral disc degeneration DOI Creative Commons
Nan Wang,

Weihao Rong,

Yimin Xie

et al.

Experimental Gerontology, Journal Year: 2024, Volume and Issue: 188, P. 112380 - 112380

Published: Feb. 22, 2024

Intervertebral disc degeneration (IVDD) constitutes a crucial pathological foundation for spinal degenerative diseases (SDD) and stands as primary contributor to both low back pain (LBP) disability. The progression of IVDD is linked structural functional alterations in tissues, where an imbalance the inflammatory microenvironment can induce extracellular matrix (ECM) degradation, senescence, apoptosis. This key pathomechanism disease's development, gaining considerable attention recent years. study aims conduct bibliometric analysis publications pertaining mechanisms quantitatively assess current research hotspots directions.

Language: Английский

Citations

2

Apigetrin alleviates intervertebral disk degeneration by regulating nucleus pulposus cell autophagy DOI Creative Commons
Tao Xu,

Hongqi Zhao,

Jian Li

et al.

JOR Spine, Journal Year: 2024, Volume and Issue: 7(2)

Published: April 17, 2024

Intervertebral disk degeneration (IVDD) is a common spine disease, and inflammation considered to be one of its main pathogenesis. Apigetrin (API) natural bioactive flavonoid isolated from various herbal medicines shows attractive anti-inflammatory antioxidative properties; whereas, there no exploration the therapeutic potential API on IVDD. Here, we aim explore role IVDD in vivo vitro.

Language: Английский

Citations

2

Molecular Basic of Pharmacotherapy of Cytokine Imbalance as a Component of Intervertebral Disc Degeneration Treatment DOI Open Access
N. А. Shnayder, A. V. Аshkhotov, Vera V. Trefilova

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(9), P. 7692 - 7692

Published: April 22, 2023

Intervertebral disc degeneration (IDD) and associated conditions are an important problem in modern medicine. The onset of IDD may be childhood adolescence patients with a genetic predisposition. With age, progresses, leading to spondylosis, spondylarthrosis, herniated disc, spinal canal stenosis. One the mechanisms development chronic back pain is imbalance between pro-inflammatory anti-inflammatory cytokines. However, classical therapeutic strategies for correcting cytokine do not give expected response more than half cases. purpose this review update knowledge about new promising based on correction molecular IDD. This demonstrates that cytokines key finding effective drugs treatment setting acute inflammation.

Language: Английский

Citations

5

Therapeutic effect and mechanism of Yougui Wan in rats with intervertebral disk degeneration DOI Creative Commons

She Ma,

Kan Liu,

Jingyan Yang

et al.

Journal of Orthopaedic Surgery and Research, Journal Year: 2024, Volume and Issue: 19(1)

Published: Jan. 25, 2024

Abstract Objective To explore the potential mechanism of Yougui Wan on deformed lumbar intervertebral disk structure in rats. Methods Thirty male Sprague–Dawley rats were randomly divided into 3 groups, with 10 each group. The animals blank control group healthy without specific treatment, and those model traditional Chinese medicine (TCM) used to establish degeneration (IDD) by puncturing annulus. Four weeks after modeling, TCM administered gavage for 2 consecutive weeks. Serum interleukin-6 (IL-10), macrophage migration inhibitory factor (MIF) tumor necrosis alpha (TNF- α ) levels measured ELISA, protein expression collagen II Notch1 tissues examined Western blotting. Apoptosis was detected TUNEL method. Results Compared group, IL-10, MIF TNF- increased ( P < 0.05), decreased, increased. IL-10 decreased increased, decreased. Conclusion can inhibit inflammatory response IDD rats, reduce degradation extracellular matrix, apoptosis nucleus pulposus cells, alleviate degeneration. may be related regulation Notch signaling pathway.

Language: Английский

Citations

1

Soft Tissue Manipulation Alters RANTES/CCL5 and IL-4 Cytokine Levels in a Rat Model of Chronic Low Back Pain DOI Open Access

Carmela L. Marciano,

Taylor Hiland,

Krista L. Jackson

et al.

Published: July 25, 2023

Low back pain (LBP) is a common musculoskeletal complaint that can impede physical function and mobility. Current management often involves medication, but there need for non-pharmacological non-invasive interventions. Soft tissue manipulation (STM) such as massage has been shown to be effective in human subjects, the molecular mechanisms underlying these findings are not well understood. In this paper, we evaluated potential changes soft levels of more than thirty pro- or anti-inflammatory cytokines following instrument-assisted STM (IASTM) rats with chronic, induced LBP using Complete Freund’s Adjuvant. Our results indicate IASTM associated reduced RANTES/CCL5 increased IL-4, which pro-inflammatory factors, respectively, by 120 minutes post-treatment. was tissue-level CXCL5/LIX (the murine homologue IL-8), CXCL7, GM-CSF ICAM-1, IL1-ra, IL-6, IP-10/CXCL10, L-selectin, TNF-α, VEGF at either 30- Combined, our suggest exerts effects improved clinical outcomes potentially beneficial pro/anti-inflammatory circulation level.

Language: Английский

Citations

2

Modern views on the pathogenesis of intervertebral disc degeneration DOI Creative Commons
N. А. Shnayder, Vera V. Trefilova, A. V. Аshkhotov

et al.

The Clinician, Journal Year: 2024, Volume and Issue: 18(1), P. 37 - 48

Published: June 24, 2024

Introduction. Intervertebral disc (IVD) degeneration is defined as a multifactorial degenerative disease of the spine, starting from structures nucleus pulposus IVD, spreading to fibrous ring and other elements spinal motion segment. Unlike natural aging, pathological process that occurs in IVDs result additive effect genetic predisposition external environmental factors leads formation chronic back pain reduces patient’s quality life. Despite many years studying problem pathogenesis IVD degeneration, it far being resolved, which encourages us further study pathogenetic mechanisms development this pathology. Aim. To update knowledge practicing neurologists about results modern studies leading humans their role promising biomarkers pathology new strategies for therapy. Materials methods. A search analysis publications was carried out Russian-language (e-Library) Englishlanguage databases (PubMed, Oxford Press, Clinical Keys, Springer, Elsevier, Google Scholar). Search depth – 5 (2018–2023). Res ults . The analyzed generalized molecular influencing progression are presented. such oxidative stress NO system, cytokine imbalance, increased activity matrix metalloproteinases, dysfunction fibrillar collagens proteoglycan, well relationship with each other, were considered. Conclusion. review provides broader look at makes possible set goals future therapeutic strategies.

Language: Английский

Citations

0

Taurine Rescues Intervertebral Disc Degeneration by Activating Mitophagy through the PINK1/Parkin Pathway DOI Creative Commons

Shengyuan Lin,

Tao Li, Bin Zhang

et al.

Biochemical and Biophysical Research Communications, Journal Year: 2024, Volume and Issue: 739, P. 150587 - 150587

Published: Aug. 22, 2024

Intervertebral disc degeneration (IDD) is a common cause of low back pain and disability. Recent studies have highlighted the critical role mitochondrial dysfunction in progression IDD. In this study, we investigated therapeutic potential taurine delaying IDD through activation mitophagy via PINK1/Parkin pathway. Our vitro vivo experiments demonstrate that treatment significantly enhances mitophagy, reduces oxidative stress, delays cell senescence, promotes removal damaged mitochondria nucleus pulposus cells (NPC). Additionally, taurine-mediated pathway leads to improved homeostasis slows degeneration. These findings provide new insights into protective effects highlight its as agent for

Language: Английский

Citations

0